Molecular diagnosis of dermatofibrosarcoma protuberans: A comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies

Genes Chromosomes and Cancer

Volumn 50, Issue 7, 2011, Pages 510-517

  Salgado, Rocío ^a,b   Llombart, Beatriz ^c   M Pujol, Ramon ^a   Fernández Serra, Antonio ^c   Sanmartín, Onofre ^c   Toll, Agustí ^a   Rubio, Luis ^c   Segura, Sonia ^a   Barranco, Carlos ^a   Serra Guillén, Carlos ^c   Yébenes, Mireia ^d   Salido, Marta ^a   Traves, Víctor ^c   Monteagudo, Carlos ^e   Sáez, Empar ^f   Hernández, Teresa ^g   de Álava, Enrique ^g   Llombart Bosch, Antonio ^e   Solé, Francesc ^a   Guillén, Carlos ^c   Espinet, Blanca ^a   López Guerrero, Jose A ^c   more..

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^d HOSPITAL DE SABADELL   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f Hospital Parc Taul   (Spain)

^g Centro de Investigacion del Cancer   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN COL1A1; PROTEIN PDGFB; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DERMATOFIBROSARCOMA PROTUBERANS; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADULT; CHILD; COLLAGEN TYPE I; DERMATOFIBROSARCOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PROTO-ONCOGENE PROTEINS C-SIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79955664776     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20874     Document Type: Article

References (37)

1. Abbott JJ, Erickson-Johnson M, Wang X, Nascimento AG, Oliveira AM. 2006. Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Mod Pathol 19: 1512-1518.
2. Abenoza P, Lillemoe T. 1993. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 15: 429-434.
3. Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G. 2010. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans. Mod Pathol 23: 434-438.
4. Bianchini L, Maire G, Guillot B, Joujoux JM, Follana P, Simon MP, Coindre JM, Pedeutour F. 2008. Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion. Virchows Arch 452: 689-696.
5. Brown LA, Huntsman D. 2007. Fluorescent in situ hybridization on tissue microarrays: Challenges and solutions. J Mol Histol 38: 151-157.
6. Craver R, Dewenter T, Ebran N, Pedeutour F. 2006. COL1A1-PDGFB fusion in a pediatric Bednar tumor with 2 copies of a der(22)t(17;22). Cancer Genet Cytogenet 168: 155-157.
7. Cribier B, Noacco G, Peltre B, Grosshans E. 2002. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. J Am Acad Dermatol 46: 408-413.
8. Fisher C. 2004. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas. Ultrastruct Pathol 28: 291-305.
9. Fisher C. 2010. Soft tissue sarcomas with non-EWS translocations: Molecular genetic features and pathologic and clinical correlations. Virchows Arch 456: 153-166.
10. Giacchero D, Maire G, Nuin PA, Berthier F, Ebran N, Carlotti A, Celerier P, Coindre JM, Esteve E, Fraitag S, Guillot B, Ranchere-Vince D, Saiag P, Terrier P, Lacour JP, Pedeutour F. 2010. No correlation between the molecular subtype of COL1A1-PDGFB fusion gene and the clinico-histopathological features of dermatofibrosarcoma protuberans. J Invest Dermatol 130: 904-907.
11. Gloster HM, Jr. 1996. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 35: 355-374.
12. Gokden N, Dehner LP, Zhu X, Pfeifer JD. 2003. Dermatofibrosarcoma protuberans of the vulva and groin: Detection of COL1A1-PDGFB fusion transcripts by RT-PCR. J Cut Pathol 30: 190-195.
13. Goldblum JR. 1995. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Arch Pathol Lab Med 119: 238-241.
14. Jain S, Xu R, Prieto VG, Lee P. 2010. Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol 3: 416-428.
15. Kim HJ, Lee JY, Kim SH, Seo YJ, Lee JH, Park JK, Kim MH, Cinn YW, Cho KH, Yoon TY. 2007. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: Comparison with factor XIIIa and CD34. Br J Dermatol 157: 319-324.
16. Kutzner H. 1993. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol 28: 613-617.
17. Llombart B, Sanmartin O, Lopez-Guerrero JA, Monteagudo C, Serra C, Requena C, Poveda A, Vistos JL, Almenar S, Llombart-Bosch A, Guillen C. 2009. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB) study with therapeutic implications. Histopathology 54: 860-872.
18. Llombart B, Monteagudo C, Sanmartín O, López-Guerrero JA, Serra-Guillén C, Poveda A, Jorda E, MD, Fernandez-Serra A, Pellín A, MD, Guillén C, MD, Llombart-Bosch A. Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB) and therapeutic study of low grade versus high grade (fibrosarcomatous) tumors. J Am Acad (Accepted for publication).
19. Macarenco RS, Zamolyi R, Franco MF, Nascimento AG, Abott JJ, Wang X, Erickson-Johnson MR, Oliveira AM. 2008. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 47: 260-265.
20. Maire G, Fraitag S, Galmiche L, Keslair F, Ebran N, Terrier-Lacombe MJ, de Prost Y, Pedeutour F. 2007. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans. Arch Dermatol 143: 203-210.
21. Maire G, Pedeutour F, Coindre JM. 2002. COL1A1-PDGFB gene fusion demonstrates a common histogenetic origin for dermatofibrosarcoma protuberans and its granular cell variant. Am J Surg Pathol 26: 932-937.
22. McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, Nikolova Z, Dimitrijevic S, Fletcher JA. 2005. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 23: 866-873.
23. Naeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA. 1995. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol 147: 1553-1558.
24. Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Yo S, Isayama T, Naito M, Kikuchi M. 2001. Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22: A fluorescence in situ hybridization and comparative genomic hybridization analysis. Genes Chromosomes Cancer 30: 305-309.
25. Patel KU, Szabo SS, Hernandez VS, Prieto VG, Abruzzo LV, Lazar AJ, Lopez-Terrada D. 2008. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum Pathol 39: 184-193.
26. Pedeutour F, Coindre JM, Nicolo G, Bouchot C, Ayraud N, Carel CT. 1993. Ring chromosomes in dermatofibrosarcoma protuberans contain chromosome 17 sequences: Fluorescence in situ hybridization. Cancer Genet Cytogenet 67: 149.
27. Pedeutour F, Simon MP, Minoletti F, Barcelo G, Terrier-Lacombe MJ, Combemale P, Sozzi G, Ayraud N, Turc-Carel C. 1996. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: A new tumor-associated chromosome rearrangement. Cytogenet Cell Genet 72: 171-174.
28. Pedeutour F, Simon MP, Minoletti F, Sozzi G, Pierotti MA, Hecht F, Turc-Carel C. 1995. Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences. Cancer Res 55: 2400-2403.
29. Rubin BP, Schuetze SM, Eary JF, Norwood TH, Mirza S, Conrad EU, Bruckner JD. 2002. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 20: 3586-3591.
30. Rutgers EJ, Kroon BB, Albus-Lutter CE, Gortzak E. 1992. Dermatofibrosarcoma protuberans: Treatment and prognosis. Eur J Surg Oncol 18: 241-248.
31. Segura S, Salgado R, Toll A, Martin-Ezquerra G, Yebenes M, Saez A, Sole F, Barranco C, Umbert P, Espinet B, Pujol RM. 2011. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays. Hum Pathol 42: 176-184.
32. Shimizu A, O'Brien KP, Sjoblom T, Pietras K, Buchdunger E, Collins VP, Heldin CH, Dumanski JP, Ostman A. 1999. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res 59: 3719-3723.
33. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, Terrier-Lacombe MJ, Mandahl N, Craver RD, Blin N, Sozzi G, Turc-Carel C, O'Brien KP, Kedra D, Fransson I, Guilbaud C, Dumanski JP. 1997. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15: 95-98.
34. Sjoblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, Dumanski JP, Ostman A, Heldin CH. 2001. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res 61: 5778-5783.
35. Stacchiotti S, Pedeutour F, Negri T, Conca E, Marrari A, Palassini E, Collini P, Keslair F, Morosi C, Gronchi A, Pilotti S, Casali PG. 2011. Dermatofibrosarcoma protuberans-derived fibrosarcoma: Clinical history, biological profile and sensitivity to imatinib. Int J Cancer (Accepted for publication).
36. Terrier-Lacombe MJ, Guillou L, Maire G, Terrier P, Vince DR, de Saint Aubain Somerhausen N, Collin F, Pedeutour F, Coindre JM. 2003. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 27: 27-39.
37. Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY, Siebert R. 2006. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 8: 141-151.